Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Synguton Aug 27, 2015 6:12pm
175 Views
Post# 24057565

Cancer breakthrough

Cancer breakthrough

Cancer cells ‘programmed’ back to normal by scientists in major breakthrough

Cancer research scientists have managed to programme cancerous cells back normal for the first time, potentially giving doctors the ability to ‘switch off’ cancer.

The breakthrough could potentially lead to the development of life-saving treatments and possibly even reverse the growth of cancerous tumours.

Published in the journal Nature Cell Biology, the study showed how aggressive breast, lung and bladder cancel cells could be changed back into harmless cells by reintroducing the function that stops them multiplying.

In normal cells, ‘biological processors’ called microRNAs trigger production of a specific protein which instructs older cells to stop dividing. In cancerous cells, not enough of the protein is delivered, causing the cells to keep multiplying into a tumour.

The study found that injecting microRNA directly into a tumour could return the cancerous cells back to normal and stop them reproducing.

Researchers at the Florida-based Mayo Clinic in the U.S. have so far only tested human cells in lab conditions, but are hopeful that the technique can be developed into a cancer-busting alternative to chemotherapy or surgery.

While this is by no means an instant cure for cancer, the findings are certainly compelling for scientists developing cancer treatments.

Speaking to The Telegraph, Dr Chris Bakal, a specialist at the Institute for Cancer Research, said:

“I think in reality it is unlikely that you could reverse tumours by reversing just one mechanism, but it’s a very interesting finding.”

Bullboard Posts